Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine Disruptors
- PMID: 33013826
- PMCID: PMC7493744
- DOI: 10.3389/fimmu.2020.01737
Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine Disruptors
Abstract
Osteoporosis stems from an unbalance between bone mineral resorption and deposition. Among the numerous cellular players responsible for this unbalance bone marrow (BM) monocytes/macrophages, mast cells, T and B lymphocytes, and dendritic cells play a key role in regulating osteoclasts, osteoblasts, and their progenitor cells through interactions occurring in the context of the different bone compartments (cancellous and cortical). Therefore, the microtopography of immune cells inside trabecular and compact bone is expected to play a relevant role in setting initial sites of osteoporotic lesion. Indeed, in physiological conditions, each immune cell type preferentially occupies either endosteal, subendosteal, central, and/or perisinusoidal regions of the BM. However, in the presence of an activation, immune cells recirculate throughout these different microanatomical areas giving rise to a specific distribution. As a result, the trabeculae of the cancellous bone and endosteal free edge of the diaphyseal case emerge as the primary anatomical targets of their osteoporotic action. Immune cells may also transit from the BM to the depth of the compact bone, thanks to the efferent venous capillaries coursing in the Haversian and Volkmann canals. Consistently, the innermost parts of the osteons and the periosteum are later involved by their immunomodulatory action, becoming another site of mineral reabsorption in the course of an osteoporotic insult. The novelty of our updating is to highlight the microtopography of bone immune cells in the cancellous and cortical compartments in relation to the most consistent data on their action in bone remodeling, to offer a mechanist perspective useful to dissect their role in the osteoporotic process, including bone damage derived from the immunomodulatory effects of endocrine disrupting chemicals.
Keywords: bone remodeling; endocrine disrupting chemical; immunobiology; immunomodulation; organoid; osteoporosis.
Copyright © 2020 Toni, Di Conza, Barbaro, Zini, Consolini, Dallatana, Antoniel, Quarantini, Quarantini, Maioli, Bruni, Elviri, Panseri, Sprio, Sandri and Tampieri.
Figures

Similar articles
-
Age- and menopause-related bone loss compromise cortical and trabecular microstructure.J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1218-25. doi: 10.1093/gerona/glt071. Epub 2013 Jul 5. J Gerontol A Biol Sci Med Sci. 2013. PMID: 23833200 Review.
-
Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.Anat Rec (Hoboken). 2007 Aug;290(8):1005-16. doi: 10.1002/ar.20561. Anat Rec (Hoboken). 2007. PMID: 17610276
-
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.Osteoporos Int. 2003;14 Suppl 3:S2-8. doi: 10.1007/s00198-002-1340-9. Epub 2003 Mar 19. Osteoporos Int. 2003. PMID: 12730770 Review.
-
Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.J Bone Miner Res. 1996 May;11(5):600-13. doi: 10.1002/jbmr.5650110508. J Bone Miner Res. 1996. PMID: 9157775
-
Endocrine disruptors and bone metabolism.Arch Toxicol. 2013 Apr;87(4):735-51. doi: 10.1007/s00204-012-0988-y. Epub 2012 Nov 29. Arch Toxicol. 2013. PMID: 23192238 Review.
Cited by
-
Tributyltin perturbs femoral cortical architecture and polar moment of inertia in rat.BMC Musculoskelet Disord. 2021 May 7;22(1):427. doi: 10.1186/s12891-021-04298-2. BMC Musculoskelet Disord. 2021. PMID: 33962613 Free PMC article.
-
The role of immune cells in modulating chronic inflammation and osteonecrosis.Front Immunol. 2022 Dec 13;13:1064245. doi: 10.3389/fimmu.2022.1064245. eCollection 2022. Front Immunol. 2022. PMID: 36582244 Free PMC article. Review.
-
Analysis and validation of biomarkers of immune cell-related genes in postmenopausal osteoporosis: An observational study.Medicine (Baltimore). 2024 May 10;103(19):e38042. doi: 10.1097/MD.0000000000038042. Medicine (Baltimore). 2024. PMID: 38728482 Free PMC article.
-
The immune factors have complex causal regulation effects on bone mineral density.Front Immunol. 2022 Oct 20;13:959417. doi: 10.3389/fimmu.2022.959417. eCollection 2022. Front Immunol. 2022. PMID: 36341399 Free PMC article.
-
Cornus officinalis: a potential herb for treatment of osteoporosis.Front Med (Lausanne). 2023 Dec 4;10:1289144. doi: 10.3389/fmed.2023.1289144. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38111697 Free PMC article. Review.
References
-
- Kanis JA. On behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. University of Sheffield, UK: World Health organization collaborating centre for metabolic bone diseases; University of Sheffield. (2007).
-
- National osteoporosis foundation. What is osteoporosis and what causes it? (2014). Available online at http://nof.org/articles/7 (accessed July 22, 2014)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials